Interferon-gamma reduces tumor-induced Ia- macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-alpha.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Immunopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8354638
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cells

  2005cited by this paper
• Characterization of immunosuppressive functions of murine peritoneal macrophages induced with various agents

  1992cited by this paper
• Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch?

  1992cited by this paper
• Human IFN-gamma up-regulates IL-2 receptors in mitogen-activated T lymphocytes.

  1990cited by this paper
• Down‐Regulation of Macrophage I‐A Expression in Tumor‐Bearing Mice

  1990cited by this paper
• Differential Tumor Necrosis Factor Production by Human Monocyte Subsets

  1990cited by this paper
• Characterization of Macrophage Subsets Regulating Murine Natural Killer Cell Activity

  1990cited by this paper
• Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions.

  1990cited by this paper
• Antiproliferative effect of IFN-gamma in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma.

  1989cited by this paper
• Tumor-induced variations in a high molecular weight inhibitory monokine.

  1989cited by this paper
• Tumor necrosis factor-alpha as a proliferative signal for an IL-2-dependent T cell line: strict species specificity of action.

  1989cited by this paper
• Interferon-gamma: a review.

  1989cited by this paper
• Changes in macrophage populations: phenotypic differences between normal and tumor-bearing host macrophages.

  1989cited by this paper
• Down-regulation of cytotoxic T lymphocyte development by a minor stimulating locus-induced suppressor cascade that involves Lyt-1+ suppressor T cells, IA- macrophages, and their factors.

  1988cited by this paper
• Comparative effects of tumor necrosis factor-alpha and IL-1 beta on mitogen-induced T cell activation.

  1988cited by this paper
• Immunomodulatory properties of recombinant murine and human tumor necrosis factor.

  1988cited by this paper
• Interferon-gamma is not an antiviral, but a growth-promoting factor for T lymphocytes.

  1988cited by this paper
• Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha.

  1988cited by this paper
• Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity.

  1988cited by this paper
• Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells.

  1988cited by this paper
• Prostaglandin E2‐Mediated Inactivation of Various Killer Lineage Cells by Tumor‐Bearing Host Macrophages

  1988cited by this paper
• Monoclonal antibodies against murine IFN-gamma abrogate in vivo tumor immunity against RSV-induced murine sarcomas.

  1987cited by this paper
• Shifts in macrophage (M phi) surface phenotypes during tumor growth: association of Mac-2+ and Mac-3+ M phi with immunosuppressive activity.

  1987cited by this paper
• Prostaglandin E2 inhibits human T-cell proliferation after crosslinking of the CD3-Ti complex by directly affecting T cells at an early step of the activation process.

  1987cited by this paper
• Prostaglandin E2 Production by Mac‐2+ Macrophages: Tumor‐Induced Population Shift

  1987cited by this paper
• The basis for the immunoregulatory role of macrophages and other accessory cells.

  1987cited by this paper
• Down-regulation of interleukin 1 production by macrophages of sarcoma-bearing mice.

  1987cited by this paper
• Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.

  1987cited by this paper
• Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages.

  1986cited by this paper
• Serum-free in vitro bioassay for the detection of tumor necrosis factor.

  1986cited by this paper
• Variations in Macrophage Antigen Phenotype: A Correlation Between Ia Antigen Reduction and Immune Dysfunction During Tumor Growth

  1986cited by this paper
• Effect of prostaglandin E2 on the gamma-interferon induction of antigen-presenting ability in P388D1 cells and on IL-2 production by T-cell hybridomas.

  1985cited by this paper
• Enhancing effect of IFN-gamma on helper T cell activity and IL 2 production.

  1985cited by this paper
• Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes.

  1985cited by this paper
• Regulation of arachidonic acid metabolism in macrophages by immune and nonimmune interferons.

  1985cited by this paper
• Inhibition of interferon-gamma may suppress allograft reactivity by T lymphocytes in vitro and in vivo.

  1985cited by this paper
• Monoclonal antibody to murine gamma interferon inhibits lymphokine- induced antiviral and macrophage tumoricidal activities

  1984cited by this paper
• Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production.

  1984cited by this paper
• Recombinant interferon-gamma increases HLA-DR synthesis and expression.

  1983cited by this paper
• Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors

  1983cited by this paper
• Regulation of macrophage suppression and cytotoxicity by interferon role of Ia-bearing macrophages.

  1982cited by this paper
• Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity

  1982cited by this paper
• Switching on the macrophage-mediated suppressor mechanism by tumor cells to evade host immune surveillance.

  1980cited by this paper
• In vitro immune blastogenesis during contact sensitivity in tumor-bearing mice. I. Description of progressive impairment and demonstration of splenic suppressor cells.

  1978cited by this paper
• Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages.

  1978cited by this paper
• A simple method for quantitative, semiquantitative, and qualitative assay of protein.

  1978cited by this paper

• Mechanisms of tumor escape: role of tumor microenvironment in inducing apoptosis of cytolytic effector cells

  2006cites this paper
• Immunosuppression in human tumor-host interaction: role of cytokines and alterations in signal-transducing molecules

  2004cites this paper
• Tumour escape: antitumour effectors too much of a good thing?

  2004cites this paper
• Mechanisms mediating the effects of IL‐3 gene expression on tumor growth

  2000cites this paper
• Myelopoietic response in tumour-bearing mice by an aggregated polymer isolated from Aspergillus oryzae.

  2000cites this paper
• Escape mechanisms in tumor immunity: a year 2000 update.

  2000cites this paper
• Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide.

  1999cites this paper
• Decreased Expression of Signal‐Transducing CD3 ζ Chains in T Cells from the Joints and Peripheral Blood of Rheumatoid Arthritis Patients

  1998cites this paper
• Tumor‐induced immune dysfunction: the macrophage connection

  1998cites this paper
• Modulation by conagenin of inflammatory mediator productions in mice given 5-fluorouracil.

  1997cites this paper
• In vitro effects of prostaglandin E2 or indomethacin on the proliferation of lymphokine-activated killer cells and their cytotoxicity against bladder tumor cells in patients with bladder cancer.

  1997cites this paper
• Escape from host-antitumor immunity.

  1997cites this paper
• Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer.

  1996cites this paper
• Hydrogen peroxide secreted by tumor‐derived macrophages down‐modulates signal‐transducing zeta molecules and inhibits tumor‐specific T cell‐and natural killer cell‐mediated cytotoxicity

  1996cites this paper
• Improvement of intestinal toxicity of 5-fluorouracil by conagenin, a low molecular immunomodulator.

  1996cites this paper
• Modulation of macrophage activity in tumor bearing mice by cytogenin.

  1995cites this paper
• Low molecular weight immunomodulators produced by microorganisms.

  1995cites this paper
• Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex

  1995cites this paper
• Eicosanoids and the immunology of cancer

  1994cites this paper
• Tumour Growth Causes Suppression of Autoreactive T‐Cell Proliferation by Disrupting Macrophage Responsiveness to Interferon‐γ

  1994cites this paper
• Macrophage priming and activation during fibrosarcoma growth: expression of c-myb, c-myc, c-fos, and c-fms.

  1994cites this paper